News blog

Eden Research

  • BY: Andrew Hore |
  • POSTED: 11/05/2012 |

Natural pesticides developer Eden Research has moved from Plus-quoted to Aim. 

Eden has a patented delivery system that it has used for natural pesticides that use the natural defence systems of plants. The encapsulation technology regulates the release of the terpenes which are the active ingredient.

Eden is awaiting EU regulatory approval for three terpenes and this should be achieved this year. Eden has already generated revenues from licensees but the EU approval will enable the business to push ahead with launching products in the EU and elsewhere.

Eden Research ended trading on Plus-quoted at a mid price of 19.5p a share – a bid/offer spread of 18p/21p. The share price was unchanged by the end of the first day’s trading on Aim. Eden is valued at £21.7m.

Download the latest AIM Journal from

© 2022 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds